X-82 to Treat Age-related Macular Degeneration

Clinical trial NCT02348359 · TERMINATED

Trial details

NCT number: NCT02348359
Sponsor: Tyrogenex
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Age-Related Macular Degeneration (AMD)Macular Degeneration Exudative Age-related Macular Degeneration AMD Macular Degeneration, Age-related, 10 Eye Diseases Retinal Degeneration Retinal Diseases

Start date: 2015-03-16
Primary completion: 2017-12-12
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.